Side-by-side comparison of AI visibility scores, market position, and capabilities
Dallas online dating portfolio (NASDAQ: MTCH) ~$3.4B 2024 revenue; Tinder subscriber decline (under 9M payers), new CEO Spencer Rascoff (Zillow co-founder) for AI/product turnaround, Hinge fastest-growing competing with Bumble.
Match Group, Inc. is a Dallas, Texas-based online dating and relationship services company — publicly traded on NASDAQ (NASDAQ: MTCH) as an S&P 500 Communication Services component — operating the world's largest portfolio of online dating platforms including Tinder (the global leader in dating app downloads and the company's primary revenue driver), Hinge (fast-growing relationship-focused app), Match.com, OkCupid, Plenty of Fish, Pairs (Japan), and Meetic (Europe) through approximately 2,700 employees serving users across 40+ countries. In fiscal year 2024, Match Group reported revenue of approximately $3.4 billion, reflecting pressure from declining Tinder paying subscribers (payers fell from a peak of ~11 million to below 9 million) as Gen Z consumers exhibit lower willingness to pay for premium tiers than millennial predecessors and as competitor dating apps (Bumble, Hinge within Match Group) attract new users. The defining leadership event of 2025 was the appointment of Spencer Rascoff — co-founder and former CEO of Zillow — as Match Group's new CEO, replacing Bernard Kim who oversaw the difficult period of subscriber decline. Rascoff brings technology product and marketplace expertise from Zillow's transformation from home search to real estate transactions, and is tasked with reinvigorating growth through AI integration and product innovation across the Match Group portfolio. Match Group was spun out as a standalone public company from IAC (InterActiveCorp) in 2020.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.